ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628917 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628917; 2) Community: the network communities that were significantly associated with the response to NSC 628917; 3) Molecule: the relationships between components within communities and NSC 628917; 4) MDR: the compounds that were significantly associated with the NSC 628917.

NSC Compound Enrichment Correlation
NSC 606985 Camptothecin Derivative 0.0303322639291194 0.46154466
NSC 609397 B817373K328 0.0303322639291194 0.21917054
NSC 616348 Irinotecan hydrochloride 0.0303322639291194 0.59065996
NSC 618939 Camptothecin Derivative 0.0303322639291194 0.50334268
NSC 621321 Null 0.0303322639291194 0.33497394
NSC 621855 Null 0.0303322639291194 0.36036258
NSC 625737 Null 0.0303322639291194 0.49399334
NSC 686368 Quinazolin-4(3H)-one, 3-ethyl- 2-[[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl]thio]- 0.0303322639291196 -0.1942487
NSC 690433 Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2,5-bis(1-hydroxyethyl)- 0.0303322639291196 -0.066757172
NSC 616511 Null 0.0303322639291198 -0.22233693
Total:106  Current:74    [First] [Prev] [Next] [Last]